MetaSystems Probes has received IVDR certification for our XCyting FISH probes for prenatal aneusomy testing – the XA aneusomy probes.
XA AneuScore III
Aneusomy Probe
- Order Number
- D-5613-100-TC
- Package Size
- (2x 10 Tests)
- Regulatory Status
- IVDR
IVDR Certification
This probe is IVDR-certified in compliance with the Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR). For organizational reasons, we currently provide only the IVDD product.
The XA AneuScore III contains different probe mixes provided in separate test vials.
The XA X/Y/18 (D-5606-100-TC)
The XA X/Y/18 enumeration probe consists of a green-labeled probe hybridizing to the centromere of the X-chromosome, an orange-labeled probe hybridizing to the centromere of the Y-chromosome and an aqua-labeled probe hybridizing to the centromere of the chromosome 18.
XA 13/18/21 (D-5607-100-TC)
The XA 13/18/21 enumeration probe consists of a green-labeled probe hybridizing to the RB1 gene region at 13q14.2, an aqua-labeled probe hybridizing to the MALT1 gene region at 18q21.3 and an orange-labeled probe hybridizing to the DSCR4 gene region at 21q22.1-22.2.
XA AneuScore III hybridized to amniocytes of two different patients. XA 13/18/21 (upper image) shows a normal signal constellation for 13q14 and 21q22, two green and two orange signals, respectively. For the 18q21 locus-specific probe three blue signals are observed. XA X/Y/18 (lower image) shows a normal signal constellation with one orange (Y centromere-specific), one green (X centromere-specific) and two blue (18 centromere-specific) signals.
For signal patterns please refer to: XA X/Y/18 (D-5606-100-TC) and
XA 13/18/21 (D-5607-100-TC).
Certificate of Analysis (CoA)
or go to CoA DatabaseIVDR Certification
MetaSystems Probes has received IVDR certification for our initial 26 fluorescence in situ hybridization (FISH) probes from the notified body, BSI. Achieving this milestone was not without its challenges, and we are delighted to have accomplished IVDR certification for this probe set at an early stage.